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The preprotachykinin-A gene, the common gene of
mRNAs encoding both substance-P (SP) and neu-
rokinin-A (NKA), was shown to be expressed in
Sprague-Dawley rat thymus by detection of specific
mRNA in gel-blot analyses. In situ hybridization re-
vealed dispersed PPT-A-labeled cells in sections
from rat thymus, with a concentration of grains over
a subpopulation of cells in the thymic medulla. Also,
neuropeptide-Y mRNA-expressing cells were found
in the rat thymus, primarily in the thymic medulla.
Rat thymic extracts contained SP-like immunoreac-
tivity (SP-LI), and the major part of the immunoreac-
tivity coeluted with authentic SP and SP sulfoxide
standards. SP-LI was also detected in human thy-
mus, which contained between 0.09-0.88 ng SP-LI/
g wet wt. Evidence for translation of preprotachyki-
nin-A mRNA in the rat thymus was obtained from the
demonstration of NKA-LI in thymic cells with an
epithelial-like cell morphology. Combined with pre-
vious observations on the immunoregulatory roles
of tachykinin peptides and the existence of specific
receptors on immunocompetent cells, the demon-
stration of intrathymic synthesis of NKA suggests a
role for NKA-LI peptides in T-cell differentiation in
the thymus. (Molecular Endocrinology 4:1211-1218,
1990)
INTRODUCTION
T-Cell differentiation occurs primarily in the thymus (1,
2), and a substantial part of this complex program is
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regulated through direct cell to cell contacts as well as
by paracrine factors locally synthesized within the
thymic environment (3-5). A number of intrathymic
paracrine factors have been isolated and characterized,
including thymic hormones (6-9), colony-stimulating
factors, and cytokines (10-12), which are synthesized
mainly by epithelial cells. In addition, antigenic markers
associated with different neuroendocrine cell types are
found within the thymus, such as the surface complex
ganglioside A2B5 (13), the secretory granule-associ-
ated protein chromogranin-A (14), neuron-specific eno-
lase (15), and the surface glycoproteins HISL-5, -9, -14
(16), and -ID4 (17). In addition, recent reports from a
number of laboratories have described the prescence
of neuropeptides in the thymus, although some species
differences may exist in the neuropeptide repertoire
detected in the organ. Neurotensin-like immunoreativity
(LI) and somatostatin-LI have been identified and bio-
chemically characterized in the chicken thymus (18).
Oxytocin (OT)-LI and neurophysin-LI have also been
described in the human thymus (19), while vasopressin
(VP)-LI has been characterized in murine and rat thymus
(20, 21). Evidence for an intrathymic expression of
these peptides has been obtained by positive hybridi-
zation in dot blot assays of thymic mRNA using OT and
VP cDNA probes (22). OT-, VP-, and neurophysin-LI
were identified by immunocytochemistry in thymic sub-
capsular cortex and medulla and in a specific subpop-
ulation derived from the outer cortex, the thymic nurse
cells (9, 15, 22). Met-Enkephalin-LI has also been de-
tected in medullary and cortical surface epithelium (23).
Recently, somatostatin mRNA has been demonstrated
in the rat thymus, thus providing evidence for an intra-
thymic synthesis of this neuropeptide (24). A local im-
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munoregulatory function have been suggested for
some of these neuropeptides, in parallel with the ob-
servation of specific receptors within the thymus or on
immunocompetent cells (25-28).
The peptides substance-P (SP) and neurokinin-A
(NKA) belong to a family of related peptides, the tachy-
kinins, that are widely distributed in both the central
and peripheral nervous system where they function as
neurotransmitters/neuromodulators (29). Recently,
Geppetti et al. (30, 31) detected SP-LI and NKA-LI in
the rat thymus that was shown to migrate largely with
synthetic SP and NKA, respectively, on reverse phase
HPLC. Capsaicin pretreatment of rats was shown to
decrease, but not abolish, SP-LI and NKA-LI in the
thymus, suggesting that the detected thymic SP-LI and
NKA-LI were derived mainly from known sensory inner-
vation of the organ.
In this study we demonstrate expression of two
neuropeptide mRNAs in the rat thymus, preprotachy-
kinin-A (PPT-A) mRNA, encoding both SP and NKA
(32), and NPY mRNA. RIAs using antisera specific for
SP also showed the presence of authentic SP in both
rat and human thymuses. In addition, immunohisto-
chemical staining revealed the presence of NKA-LI in
rat thymus. Hence, PPT-A-related peptides may be
locally synthesized in the primary lymphoid organ, and
since specific SP receptors and actions have been
described on a subpopulation of T-cells (33, 34), we
suggest that intrathymic tachykinin peptides may play
a role in T-cell differentiation.
RESULTS
Tissue distribution of rat PPT-A mRNA
To study the tissue distribution of PPT-A mRNA, poly-
adenylated RNA was prepared from several adult Spra-
gue-Dawley rat tissues, fractionated on denaturing aga-
rose gels, and blotted to nitrocellulose filters, followed
by hybridization to a 32P-labeled rat PPT-A cDNA probe
common to both SP and NKA. As expected (32), high
levels of a 1.3-kilobase (kb) long PPT mRNA was found
in the brain. In addition, a same size PPT mRNA was
found in the rat thymus (Fig. 1). The level of PPT mRNA
in the thymus, measured by densitometer scanning of
autoradiograms from three independent experiments,
was approximately 10 times lower than the level of PPT
mRNA in rat brain. No other rat tissue analyzed, includ-
ing the spleen, contained detectable levels of PPT
mRNA. Furthermore, no PPT transcript was detected
in mRNA prepared from isolated rat spleen cells (data
not shown).
Localization of PPT-A mRNA in the Rat Thymus by
in situ Hybridization
The rat PPT-A cDNA probe showed dispersed labeling
over sections from the rat thymus, with the highest
labeling occurring over the thymic medulla (Fig. 2, a and
1.3 k b -
Fig. 1. Expression of PPT mRNA in Various Rat Tissues
Polyadenylated RNA (20 Mg/slot) prepared from the indi-
cated tissues of adult Sprague-Dawley rats was electropho-
resed in a 1% agarose gel containing 0.7% formaldehyde. The
RNA was then transferred to a nitrocellulose filter and hybrid-
ized to a nick-translated 300-bp BglW-BstEW fragment from a
rat PPT cDNA clone. The filter was washed at high stringency,
followed by exposure to x-ray film.
b). Analysis of the sections at higher magnification by
emulsion autoradiography revealed the highest concen-
tration of grains overlying a subpopulation of dispersed
cells in the medulla (Fig. 3a). No, or very few, labeled
cells were seen in the thymic cortex or the subcapsular
region. No specific labeling was seen using a rat brain-
specific cDNA clone also expressed in mitogen-stimu-
lated spleen cells, but not in the thymus, included as a
negative hybridization control (clone NI-2, Ericsson, A.,
G. Barbany, and H. Persson, manuscript submitted for
publication; Figs. 2, e and f, and 3c). Moreover, no
labeling over sections from rat thymus was seen using
vector sequences (pUC 9 DNA) as a negative hybridi-
zation control (data not shown).
Localization of NPY mRNA-Expressing Cells in Rat
Thymus
The rat NPY gene has previously been shown to be
expressed at a low level in the rat thymus (35). A DNA
probe specific for rat NPY mRNA (35) was therefore
used in an attempt to localize neuropeptide-Y (NPY)
mRNA expressing cells in the rat thymus. This probe
revealed specific labeling over sections from rat thymus
(Fig. 2, c and d). As in the case of PPT, NPY mRNA-
expressing cells in the thymus were found in the me-
dulla, where a small subpopulation of cells was labeled
(Fig. 3b). Both the PPT and NPY probes showed the
expected neuronal labeling pattern on sections from rat
brain hybridized in parallel with the thymus sections
(data not shown).
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Fig. 2. In Situ Hybridizations to Sections from Rat Thymus
Cryostat sections from adult Sprague-Dawley rat thymus were hybridized to a 300-bp fig/ll-SsfEII fragment from a rat PPT cDNA
clone (a and b), a 287-bp Xho\-Ava\ fragment containing the second exon of the rat NPY gene (c and d), and a 500-bp EcoR\
fragment from a rat cDNA clone, designated NI-2, not expressed in the thymus (e and f). All probes were labeled to the same
specific activity with [«-35S]dATP by nick translation, a, c, and e are brightfield micrographs and b, d, and f are darkfield micrographs
obtained after emulsion autoradiography of the sections, ctx and med denote thymic cortex and medulla, respectively. Note the
concentration of labeling over the thymic medulla in b and d. Scale bars are 125 ^m.
RIA of SP-LI in Rat and Human Thymus Extracts
SP-LI was detected with either of two polyclonal SP
antisera in a pool of rat thymuses as well as in each of
five different human thymuses. The dilution curves of
the different samples were strictly parallel to the stand-
ard curves of the RIAs. Figure 4 shows the results
obtained with polyclonal SPA antiserum. Concentrations
of SP-LI were in the same range using either of the two
polyclonal antisera in the RIAs [0.3 ± 0.03 (mean ± SD)
ng/g wet wt in the rat thymus and between 0.09 ± 0.01
and 0.88 ± 0.11 ng/g wet wt in the human samples].
No significant correlation was found between the levels
of thymic SP-LI and the age of the patients. The highest
intrathymic SP-LI content was found in a sample ob-
tained postoperatively from an 8-month-old boy.
Chromatographic Description of SP-LI in Thymic
Extracts
Combined reverse phase HPLC/RIA analyses of SP-LI
in thymic extracts showed a major peak (60-70% of
the total immunoreactivity) that coeluted with an au-
thentic SP standard (Fig. 5). The remaining peak (30-
40%) eluted slightly later than synthetic NKA and at a
position corresponding to authentic SP sulfoxide stand-
ard. Similar profiles were obtained after analyzing SP-
LI detected by antiserum SP2 (data not shown).
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Fig. 3. Emulsion Autoradiographs of Sections from Rat Thy-
mus
Sections from adult Sprague-Dawley rat thymus were hy-
bridized to the PPT-A probe (a), the NPY probe (b), and the
control NI-2 probe (c). Scattered hybridization-positive cells
(arrows) can be seen over the thymic medulla in a and b. Also
note the absence of labeling over any cells in the thymus in c,
included as a negative hybridization control. Scale bars are 60
Detection of Tachykinin-LI in Rat Thymic Cells
Sections from rat thymus were immunostained using
• • . SP Mltnd,
CONCENTRATION <M>
Fig. 4. Detection of SP-LI in Rat and Human Thymuses
Shown in the figure is a standard curve from the SP RIA
using the SPA antiserum, as well as dilution curves of extracts
prepared from five different human thymuses and a pool of six
rat thymuses also using the SPA antiserum.
either a polyclonal SP antiserum or a polyclonal NKA
antiserum. No specific immunostaining was seen with
the SP antiserum (data not shown). However, the NKA
antiserum revealed a specific immunostaining of
stromal cells throughout the thymic parenchyma, with
a predominance in the medullary area (Fig. 6). Double
immunoflourescence analysis was performed with a
A2B5-specific antiserum as well as KL 4 monoclonal
antibodies against human cytokeratin. NKA-LI-contain-
ing cells were also specifically stained with the A2B5
antiserum and contained cytokeratin-LI, demonstrating
their epithelial nature (data not shown). All NKA-LI in
the rat thymus was abolished after absorbtion of the
antiserum to a synthetic NKA peptide (data not shown).
DISCUSSION
The results reported here confirm the recent observa-
tions describing the presence of SP-LI in the rat thymus
(30) and, in addition, demonstrate the existence of this
neuropeptide in the human thymic gland. Moreover,
RNA blot analyses were used to demonstrate a local
synthesis of PPT-A mRNA in the rat thymus. In the rat
brain three different forms of PPT-A mRNA of similar
length (a, 0, and 7), generated by differential RNA
processing, have been detected (32). Both SP and NKA
are encoded by the /3 and 7 forms, whereas the a form
only encodes SP. The cDNA probe used in this study
detects all three forms of PPT-A mRNA, but due to their
similar size the results of the Northern blot analyses
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Fig. 5. Reverse Phase HPLC Profile of SP-LI Contained in Rat Thymus and Different Human Thymic Extracts
The arrows denote the elution positions of synthetic SP, SP-(4-11), NKA, and NKB run on the same column after analysis of the
thymic extracts.
Fig. 6. Immunofluorescence Micrographs of Rat Thymus after
Incubation with NKA Antiserum
Specific immunostaining can be seen in the thymic medulla
with an epithelial cell-like morphology. Bar is 16 ^m.
cannot be used to determine if all three forms or only
one or two of the forms are expressed in the rat thymus.
In situ hybridization analyses demonstrated the pres-
ence of low levels of PPT-A mRNA in cells located
predominantely in the thymic medulla. However, only a
minor fraction of the cells in the medulla was labeled,
suggesting that PPT-A mRNA expression is restricted
to a small subpopulation of thymic medulla cells. Alter-
natively, the gene may be expressed in a larger popu-
lation of thymic medulla cells, but only during a re-
stricted time interval. An identification of the cell types
expressing PPT-A mRNA in the rat thymic medulla
would require combined in situ hybridization and im-
munohistochemical staining on the same section, using
antisera directed against antigenic markers specific for
different cell types in the thymus. However, the absense
of detectable PPT-A mRNA in rat spleen and isolated
rat spleen cells suggests that PPT-A mRNA is not
expressed in mature T-cells. Also, the thymic nurse
cells located in the outer thymic epithelium that synthe-
size OT and VP (9,15, 22) are less likely to be the site
of PPT-A mRNA synthesis in the thymus, given the
almost complete absense of labeling in the thymic cor-
tex. Alternative sites could be a subset of the thymic
epithelial cells that express neuroendocrine antigenic
markers (13-17, 36) as well as different peptides (6-9,
18,36). In support of this, NKA-LI was deteceted in rat
thymus in cells with a morphology resembling thymic
epithelial cells. Surprisingly, however, immunostaining
of rat thumus with a SP-specific antiserum showed no
SP-LI-containing cells in the rat thymus. This may be
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due to an inability of the SP antiserum to detect SP
peptides in fixed tissue sections from the thymus or
may be explained if PPT-A mRNA in the rat thymus is
only translated into NKA peptides. Interestingly, Gep-
petti et al. (31) described and charaterized, by combined
HPLC-RIA, NKA-LI in the rat thymus and showed that
it was less sensitive to capsaicin than SP-LI. Hence,
NKA peptides may be locally translated from the PPT-
A mRNA in the thymus, which is further supported by
our demonstration of NKA-immunoreactive cells in the
rat thymus.
A hybridization pattern similar to the one for PPT-A
mRNA was seen using a rat NPY probe. NPY mRNA
and peptide have previously been detected in rat meg-
akaryocytes and thrombocytes, and low levels of NPY
were also detected in rat thymus by RNA blot analysis
(37,38). The finding of NPY mRNA in a subset of thymic
medulla cells provides another example of a nonneu-
ronal expression of NPY mRNA in the rat and suggests
that NPY may serve a function in the thymus similar to
that of tachykinin peptides.
A biochemical characterization of the SP-LI detected
in the rat and human thymus using reverse phase HPLC
revealed that 60-70% of SP-LI was identical to authen-
tic SP. Hence, a major fraction of the intrathymic SP
corresponds to the biologically active form found in
nervous tissues. The remaining SP-LI did not corre-
spond to synthetic SP. The very low cross-reactivity of
the antisera used in this study with NKA or NKB
strongly suggests that this additional peak was not
NKA or NKB, but most likely represented the oxidized
form of SP which eluted off the column at this position.
Capsaicin treatment has previously been shown to
decrease the level of SP-LI in rat thymus (30), suggest-
ing that the previously detected SP-LI was at least in
part derived from sensory nervous structures innervat-
ing the rat thymus. The relatively low amount of SP-LI
detected in both the rat and human thymus together
with the inability to detect SP-LI in thymic cells suggest
that the major part of SP-LI described in this study is
derived from sensory innervation of the thymus.
Specific high affinity binding sites for SP have been
described in the rat thymic medulla, in association with
vascular structures (39). Therefore, SP may function as
a paracrine factor, perhaps regulating the local blood
flow. Alternatively, tachykinin peptides, locally synthe-
sized within the thymus, may play a role in the immune
system. Previously, SP has also been shown to stimu-
late the mitotic activity of cultured human T-cells (33)
and induce the release of cytokines from human periph-
eral blood monocytes (40); recently, NKA has been
shown to stimulate proliferation of murine thymocytes
in culture (41). Both SP and NKA have also been shown
to stimulate differentiation of human B-lymphocytes into
immunoglobulin-producing cells (42). In agreement with
these biological activities, specific receptors for SP have
been detected on macrophages and human T-cell pop-
ulations (34, 43). Hence, the local synthesis of tachyki-
nin peptides within rat and possibly human thymus
together with the previous demonstrations of specific
SP receptors on immunocompetent cells suggest that
they may play a role in the process of T-cell differentia-
tion and/or early activation that occurs primarily in the
thymus.
MATERIALS AND METHODS
RNA Preparation and Blot Analysis
The indicated organs were dissected from adult (150-200 g
BW) Sprague-Dawley rats. All tissues were frozen in liquid
nitrogen and stored at -70 C before RNA preparation, as
previously decribed (44). Briefly, the frozen tissue samples
were homogenized in 4 M guanidine isothiocyanate, 0.1 M /3-
mercaptoethanol, and 0.025 M sodium citrate (pH 7.0) and
centrifuged at 15 C in a Beckman SW41 rotor (Palo Alto, CA)
at 35,000 rpm for 16 h. Poly(A)+ RNA was isolated by oligo(dT)-
cellulose chromatography (45), and the recovery of RNA was
quantified spectrophotometrically before use in RNA blot
analysis. Poly(A)+ RNA (20 ng) from each sample was electro-
phoresed in a 1% agarose gel containing 0.7% formaldehyde
and transferred to a nitrocellulose filter. The blotted RNA was
then hybridized to a 300-basepair (bp) BglW-BstBW fragment
from a rat PPT cDNA clone kindly provided by Dr. Shigetada
Nakanishi, Kyoto University, Japan. This fragment hybridizes
to a 1.3-kb PPT mRNA encoding either SP alone or both NKA
and SP (32). For hybridization to NPY mRNA, a 287-bp Xbal-
Ava\ fragment containing exon 2 of the NPY gene was used
(35). The fragments were labeled with [«-32P]dCTP by nick
translation to a specific activity of approximately 5 x 108 cpm/
ng. Hybridization was carried out in 4 x SSC (1 x SSC is 150
mM NaCI and 15 mM sodium citrate, pH 7.0), 40% formamide,
1 x Denhardt's solution, and 10% dextran sulfate at 42 C.
Filters were washed at high stringency (0.1 x SSC-0.1 sodium
dodecyl sulfate; 54 C) and exposed to Kodak XAR-5 films
(Eastman Kodak, Rochester, NY). The same filters as those
used for PPT hybridization were boiled for 5 min in 1% glycerol
and then probed with a nick-translated 1.5-kb Pst\ fragment
encoding mouse a-actin (46). Appropriate exposures of all
autoradiograms were quantified using a Shimadzu (Kyoto,
Japan) CS-9000 densitometer. The level of PPT mRNA was
then normalized relative to the level of actin mRNA.
In Situ Hybridization
In situ hybridization was carried out essentially as described
by Emfors et al. (44), with some minor modifications. Briefly,
pieces of rat thymus were fresh frozen, and 14-/tm thick
sections were cut on a cryostat and thawed onto poly-L-lysine
(50 Mg/ml)-pretreated slides. The sections were subsequently
fixed in 4% paraformaldehyde for 30 min and rinsed twice in
PBS. The sections were then acetylated in 0.1 M triethanola-
mine, pH 8.0, containing 0.25% acetic anhydride for 10 min.
After rinsing in 2 x SSC, followed by one rinse in 1 x PBS,
the sections were immersed in 0.1 M Tris-HCI (pH 7.0) and 0.1
M glycine for 30 min. Dehydration was carried out in a graded
series of ethanol, including a 5-min incubation in chloroform,
followed by a brief air drying. The sections were prehybridized
for 2 h at 42 C in 50% formamide, 4 x SSC, 1 x Denhardt's
solution (0.02% polyvinylpyrrolidone, 0.02% Ficoll, and 0.02%
BSA), 10% dextran sulfate, 0.25 mg/ml yeast tRNA, 0.5 mg/
ml sheared salmon sperm DNA, 1% sarcosyl (AMauroyl sar-
cosine), 0.02 M NaPO4 (pH 7.0), and 0.05 M dithiothreitol. The
same DNA fragments as those used for RNA blot analysis
were also used to detect PPT and NPY mRNA by in situ
hybridization. As a negative control probe, a 500-bp EcoRI
fragment from a cDNA clone encoding the rat brain antigen Nl
2 was used. This fragment contains the 3'-untranslated region
of a gene expressed in the rat brain and mitogen-stimulated
spleen cells, but not in rat thymus, as determined by RNA blot
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analysis (Ericsson, A., G. Barbany, and H. Persson, manuscript
submitted for publication). The DNA probes were labeled with
[a-^SJdATP by nick-translation to a specific activity of approx-
imately 5 x 108 cpm//*g. Hybridization was performed at 42 C
for 15 h in a humidified chamber with 100 ^ I/slide hybridization
cocktail containing 1 x 106 cpm labeled probe. The slides
were subsequently rinsed, washed four times for 15 min each
at 55 C in 1 x SSC, and then air dried. The sections were
dipped in Kodak NTB-2 photoemulsion, diluted 1:1 in water,
exposed for 10 weeks at - 20 C, developed, and fixed, fol-
lowed by counterstaining with cresyl violet. Light- and darkfield
micrographs were obtained using a Nikon Microphot-FX mi-
croscope. For darkfield micrographs, epiluminiscent UV light
and a Nikon IGS filter was used to reduce tissue autofloures-
cene and quenching of light over cells densely stained with
cresyl violet.
Extraction of SP-LI from Thymic Tissues
Thymic lobes were dissected from children undergoing ster-
notomy for cardiac surgery. A pool of six thymuses was
obtained from adult Sprague-Dawley rats after cervical dislo-
cation. SP extraction was performed as previously described
(47). Briefly, small pieces of thymus were placed for 10 min
into boiling 0.5 M acetic acid (1:10, wt/vol) and then centrifuged
at 4 C at 1600 x g for 10 min. Supematants were collected,
lyophilized, and stored at -20 C until further analyses. The
estimated recovery of exogenously added SP in the extraction
procedure was 76.5 ± 2.4%.
SP-Specific RIA
Two polyclonal SP-specific antisera were used for the RIA.
The first antiserum (SP2) was kindly provided by Dr. Ernst
Brodin, Karolinska Institute (Stockholm, Sweden), and this
antiserum has previously been characterized and used for SP
RIA, as detailed by Brodin ef a/. (48). The other antiserum
(SPA) was raised in rabbits after sc injections of SP conjugated
to BSA using diflourodinitrobenzene (49). [Tyr'JSP was radio-
iodinated using a slight modification of the chloramine-T
method. For assays, lyophilisates were first reconstituted in
0.05 M phosphate buffer, pH 7.5, containing 0.5% BSA and
0.05% sodium azide. One hundred-microliter samples or
standard SP were incubated with 100 n\ SP2 (initial dilution,
1:50,000) or SPA (initial dilution, 1:75,000) for 24 h at 40 C.
One hundred microliters of 125l-[Tyr3]SP (±30,000 cpm) were
then added together with normal rabbit serum (1:100), and the
incubation was continued for 24 h at the same temerature.
After the addition of 1 ml buffer containing 6% polyethylene
glycol 6000, goat antirabbit antiserum (1:200), 0.5% Tween-
20, and 0.02% inactive cellulose, the samples were incubated
for 20 min at room temperature, and bound and free antigen
were separated by centrifugation at 2,700 x g at 200 C for 15
min. The sensitivity of the assays was 3 pg/ml. Both antisera
reacted to 100% with synthetic SP, fragment SP-(4-11), [Tyr3]
SP, and [Tyr^SP. Cross-reactivity was only 1% with fragment
SP-(7-11) and less than 0.01% with fragment SP-(1-4), NKA,
and NKB. Synthetic SP, NKA, NKB, SP fragments, [Tyr^SP,
and [Tyr^SP were purchased from UCB-Bioproducts (Braine
I'Alleud, Belgium). Intra- and interassay coefficients of variation
were 6% and 8%, respectively.
Reverse Phase HPLC
Lyophilized extracts of rat and human thymuses were redis-
solved in 0.1% CF3COOH-20% CH3CN, filtered, and injected
on a 5-jtm Bondapak C18 column (Waters Associates, Mil-
ford, MA) equilibrated in the solvent. Elution was performed at
a flow rate of 1 ml/min, with a linear gradient of 0.5% CH3CN/
min. Fractions of 0.5 ml were collected and lyophilized. The
system was calibrated using UV-detectable amounts of syn-
thetic SP, fragment SP-(4-11), NKA, and NKB. Standard prep-
arations were run after analysis of the thymic extracts to avoid
any artefactual shadowing effect.
Immunochemistry
Frozen pieces of rat thymus were sectioned (3-5 nm thick) on
a cryostat, followed by fixation in 15% picric acid and 2%
paraformaldehyde. After rinsing, the sections were processed
for indirect immunoflourescence and incubated at 4 C with
polyclonal SP2 antiserum (diluted 1:100) (48) or the polyclonal
antiserum NKA2 against NKA (diluted 1:200) (48). Control
experiments included preincubations of the antiserum with
their homologous antigens (1 ^M) as well as solid phase
absorbtion of antiserum NKA2 with 3 mg NKA (Peninsula,
Belmont, CA) coupled to 0.1 g CnBr-activated Sepharose 4b
beads, handled as recommended by the manufacturer (Phar-
macia, Uppsala, Sweden). Double immunoflourescence anal-
yses with A2B5 crude supernatant or KL 4 antiserum were
performed as previously described (15).
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